Drugmakers Play The Patent Game To Lock In Prices

Drug companies typically have less than 10 years of exclusive rights once a drug hits the marketplace They can extend their monopolies by layering in secondary patents using tactics critics Herzberg said he fears the patent could keep prices high and make it more difficult for poor addicts to get treatment